CN114190487A - Active nutritional factor composition for preventing air particles from damaging dog and cat organisms, product containing active nutritional factor composition and preparation method - Google Patents
Active nutritional factor composition for preventing air particles from damaging dog and cat organisms, product containing active nutritional factor composition and preparation method Download PDFInfo
- Publication number
- CN114190487A CN114190487A CN202111546343.4A CN202111546343A CN114190487A CN 114190487 A CN114190487 A CN 114190487A CN 202111546343 A CN202111546343 A CN 202111546343A CN 114190487 A CN114190487 A CN 114190487A
- Authority
- CN
- China
- Prior art keywords
- factor composition
- active nutritional
- nutritional factor
- vitamin
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 124
- 235000003170 nutritional factors Nutrition 0.000 title claims abstract description 89
- 241000282326 Felis catus Species 0.000 title claims abstract description 76
- 239000002245 particle Substances 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 49
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 44
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 44
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 44
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 40
- 235000013305 food Nutrition 0.000 claims abstract description 30
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 23
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims abstract description 23
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 23
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract description 23
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 23
- 239000011720 vitamin B Substances 0.000 claims abstract description 23
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 22
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 22
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 22
- 229960000304 folic acid Drugs 0.000 claims abstract description 22
- 235000019152 folic acid Nutrition 0.000 claims abstract description 22
- 239000011724 folic acid Substances 0.000 claims abstract description 22
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 22
- 239000011718 vitamin C Substances 0.000 claims abstract description 22
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 22
- 229940046009 vitamin E Drugs 0.000 claims abstract description 22
- 239000011709 vitamin E Substances 0.000 claims abstract description 22
- 229930182493 triterpene saponin Natural products 0.000 claims abstract description 21
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 20
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 20
- 241001122767 Theaceae Species 0.000 claims abstract description 20
- 235000012754 curcumin Nutrition 0.000 claims abstract description 20
- 239000004148 curcumin Substances 0.000 claims abstract description 20
- 229940109262 curcumin Drugs 0.000 claims abstract description 20
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000012661 lycopene Nutrition 0.000 claims abstract description 20
- 239000001751 lycopene Substances 0.000 claims abstract description 20
- 229960004999 lycopene Drugs 0.000 claims abstract description 20
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 20
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 20
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 20
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims description 106
- 241000282472 Canis lupus familiaris Species 0.000 claims description 64
- 239000003094 microcapsule Substances 0.000 claims description 43
- 238000002156 mixing Methods 0.000 claims description 34
- 235000016709 nutrition Nutrition 0.000 claims description 32
- 239000000654 additive Substances 0.000 claims description 29
- 230000000996 additive effect Effects 0.000 claims description 25
- 238000003756 stirring Methods 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 18
- 235000011888 snacks Nutrition 0.000 claims description 16
- 241000287828 Gallus gallus Species 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 239000003995 emulsifying agent Substances 0.000 claims description 12
- 239000000839 emulsion Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 230000001007 puffing effect Effects 0.000 claims description 11
- 238000001694 spray drying Methods 0.000 claims description 10
- 238000001291 vacuum drying Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000005507 spraying Methods 0.000 claims description 8
- 238000005496 tempering Methods 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000013355 food flavoring agent Nutrition 0.000 claims description 5
- 239000008041 oiling agent Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000013618 particulate matter Substances 0.000 claims description 4
- 238000000748 compression moulding Methods 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 230000006378 damage Effects 0.000 description 32
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 28
- 230000035764 nutrition Effects 0.000 description 26
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 235000013616 tea Nutrition 0.000 description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 16
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 16
- 239000013642 negative control Substances 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 16
- 235000019359 magnesium stearate Nutrition 0.000 description 14
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 description 14
- 239000007779 soft material Substances 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000007921 spray Substances 0.000 description 12
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 11
- 208000023504 respiratory system disease Diseases 0.000 description 11
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 10
- 229910000019 calcium carbonate Inorganic materials 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 10
- 239000008108 microcrystalline cellulose Substances 0.000 description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 210000002345 respiratory system Anatomy 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 235000019158 vitamin B6 Nutrition 0.000 description 8
- 239000011726 vitamin B6 Substances 0.000 description 8
- 229940011671 vitamin b6 Drugs 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 238000007873 sieving Methods 0.000 description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 108010073771 Soybean Proteins Proteins 0.000 description 6
- 241000209140 Triticum Species 0.000 description 6
- 235000021307 Triticum Nutrition 0.000 description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
- 229930003316 Vitamin D Natural products 0.000 description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 235000021329 brown rice Nutrition 0.000 description 6
- 230000002612 cardiopulmonary effect Effects 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 235000019710 soybean protein Nutrition 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 235000019166 vitamin D Nutrition 0.000 description 6
- 239000011710 vitamin D Substances 0.000 description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- 229940046008 vitamin d Drugs 0.000 description 6
- 206010006458 Bronchitis chronic Diseases 0.000 description 5
- 241000282465 Canis Species 0.000 description 5
- 201000003883 Cystic fibrosis Diseases 0.000 description 5
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 5
- 108010053775 Nisin Proteins 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 238000003915 air pollution Methods 0.000 description 5
- 238000010171 animal model Methods 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 206010006451 bronchitis Diseases 0.000 description 5
- 208000007451 chronic bronchitis Diseases 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- 239000004309 nisin Substances 0.000 description 5
- 235000010297 nisin Nutrition 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 4
- 241000272525 Anas platyrhynchos Species 0.000 description 4
- 241000972773 Aulopiformes Species 0.000 description 4
- 244000298479 Cichorium intybus Species 0.000 description 4
- 235000007542 Cichorium intybus Nutrition 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 239000011665 D-biotin Substances 0.000 description 4
- 235000000638 D-biotin Nutrition 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 241000282324 Felis Species 0.000 description 4
- 235000019733 Fish meal Nutrition 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 244000017020 Ipomoea batatas Species 0.000 description 4
- 235000002678 Ipomoea batatas Nutrition 0.000 description 4
- 240000004713 Pisum sativum Species 0.000 description 4
- 235000010582 Pisum sativum Nutrition 0.000 description 4
- 244000178231 Rosmarinus officinalis Species 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 235000013345 egg yolk Nutrition 0.000 description 4
- 210000002969 egg yolk Anatomy 0.000 description 4
- 239000004467 fishmeal Substances 0.000 description 4
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 4
- 229940107187 fructooligosaccharide Drugs 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 230000001678 irradiating effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000008935 nutritious Nutrition 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 4
- 229940066675 ricinoleate Drugs 0.000 description 4
- 235000019515 salmon Nutrition 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 229940091258 selenium supplement Drugs 0.000 description 4
- 229960003080 taurine Drugs 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 3
- 241000168525 Haematococcus Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 235000012055 fruits and vegetables Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000512259 Ascophyllum nodosum Species 0.000 description 2
- 235000019743 Choline chloride Nutrition 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 239000004470 DL Methionine Substances 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000168517 Haematococcus lacustris Species 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 241000196252 Ulva Species 0.000 description 2
- 240000000851 Vaccinium corymbosum Species 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 240000001717 Vaccinium macrocarpon Species 0.000 description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229960003178 choline chloride Drugs 0.000 description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 235000004634 cranberry Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000006109 methionine Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000008621 organismal health Effects 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229960001471 sodium selenite Drugs 0.000 description 2
- 239000011781 sodium selenite Substances 0.000 description 2
- 235000015921 sodium selenite Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001653 FEMA 3120 Substances 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- HDIFHQMREAYYJW-XGXNLDPDSA-N Glyceryl Ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCC(O)CO HDIFHQMREAYYJW-XGXNLDPDSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 240000005819 Magnolia denudata Species 0.000 description 1
- 235000016094 Magnolia denudata Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 235000004552 Yucca aloifolia Nutrition 0.000 description 1
- 235000012044 Yucca brevifolia Nutrition 0.000 description 1
- 235000017049 Yucca glauca Nutrition 0.000 description 1
- 240000005780 Yucca gloriosa Species 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 210000001552 airway epithelial cell Anatomy 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004082 barrier epithelial cell Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 210000000424 bronchial epithelial cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000004890 epithelial barrier function Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940116338 glyceryl ricinoleate Drugs 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- DEDOPGXGGQYYMW-UHFFFAOYSA-N molinate Chemical compound CCSC(=O)N1CCCCCC1 DEDOPGXGGQYYMW-UHFFFAOYSA-N 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000003456 pulmonary alveoli Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000012488 skeletal system development Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Fodder In General (AREA)
Abstract
The invention discloses an active nutritional factor composition for preventing air particles from damaging dog and cat organisms, a product containing the composition and a preparation method, and relates to the technical field of pet foods. The active nutritional factor composition comprises the following raw material components in parts by weight: 0.05-0.15 part of vitamin E, 60.01-0.05 part of vitamin B, 0.01-0.05 part of folic acid, 0.03-0.15 part of vitamin C, 0.01-0.5 part of Omega3 fatty acid, 0.01-0.1 part of natural triterpene saponin, 0.01-0.1 part of curcumin, 0.01-0.1 part of lycopene and 0.01-0.1 part of tea polyphenol. The product of the invention contains the active nutritional factor composition, has good effect on preventing air particles from damaging dog and cat organisms, and has simple preparation method and wide popularization and application prospect.
Description
Technical Field
The invention relates to the technical field of pet foods, in particular to an active nutritional factor composition for preventing air particles from damaging dog and cat organisms, a product containing the composition and a preparation method.
Background
Atmospheric particulate pollution, particularly PM2.5 and PM10, is the fourth largest risk factor for death, causing illness or premature death worldwide. PM2.5 and PM10 refer to particulate matter in the atmosphere with a diameter less than or equal to 2.5 and 10 μm, which can carry various harmful substances (carcinogens, pathogens, etc.) to diffuse directly into the small airways and alveoli. The long-term exposure to air particulate pollution can cause the damage of cardiovascular and cerebrovascular tissues of organisms and the reduction of lung function, and serious diseases such as chronic obstructive pulmonary diseases and even lung cancer and the like.
Air pollution is mainly harmful to the survival and development of organisms through three pathways: one is to cause the death of the poisoning or exhaustion of the organism; secondly, the normal development of organisms is slowed down; thirdly, the resistance of the organism to diseases is reduced. The large amount of fine particles floating in the air is the main cause of this haze weather. The fine particles have the characteristics of small particles and large specific surface area, so that toxic and harmful substances such as polycyclic aromatic hydrocarbon, heavy metal and the like can be adsorbed; and because of its light weight, can stay in the atmosphere for a long time and is difficult to dissipate, is easy to be inhaled into the respiratory tract by organisms, and then directly reaches the alveolus to enter the blood circulation, causing harm to the health of the organisms. The urban fine particles can adsorb various harmful substances and enter the blood circulation in vivo along with the respiration, thus greatly harming the health.
A large amount of epidemiological survey data show that the atmospheric particulates can cause damage to various tissue systems such as a respiratory system, a heart-brain system, a nervous system, an immune system and the like, and increase the risk of suffering from cancer. Harmful substances (polycyclic aromatic hydrocarbon, heavy metal ions, carbon particles and the like) contained in the fine particles enter a lung respiratory system along with respiration, adhere to the surface of lung epithelial cells and are immersed in the lung epithelial cells, so that a defense barrier formed by the epithelial cells is broken through, and an injury mechanism is generated in the cells. The pathogenic mechanism of atmospheric particulates is complex, and the influence of atmospheric particulates on the health of organisms cannot be explained by one or more simple damage mechanisms, and the damage mechanism of the atmospheric particulates to the organisms needs to be deeply excavated and systematically researched by a plurality of researchers.
Air pollution poses similar hazards to animals as to humans. Animals and humans co-exist in an atmosphere. Air pollution is harmful to human beings, and animals cannot survive. All atmospheric pollution events that cause serious harm to humans also cause the same harm and impact to animals. The harm of air pollution to animals, in addition to the damage caused by the direct invasion of pollutants, also enters the body through contaminated foods, resulting in morbidity and mortality. Because animals are not capable of selection and identification, they will be more susceptible to contamination damage and impact than humans. Outdoor activities of pet dogs and cats, especially in winter, are extremely harmful to haze. It has been reported that the harm of air pollutants to dogs and cats is mainly reflected in: (1) respiratory tract infection: the dog-cat health-care product is one of the most common hazards of haze to dogs, a large amount of harmful substances in haze weather enter bodies of dogs and cats through the breathing of the dogs so as to cause the upper respiratory tract infection of the dogs and cats, and the symptoms of rhinorrhea, dyspnea and the like are common symptoms of the dogs and cats at the time. (2) Causing diseases of the heart and lung: haze can cause respiratory diseases of dogs, further possibly cause lung diseases, and further possibly cause pneumonia, lung cancer and cardiovascular and cerebrovascular diseases. (3) Infection with viral infectious diseases: if there are various canine infectious diseases outbreaks at the time of haze, the viruses spread by attaching to fine particles which are difficult to disperse because of floating in the air in the haze weather, so if the air is inhaled by dogs and cats at this time, the infectious disease viruses are very easily infected. (4) The harm haze to eyes not only affects the breathing of dogs and cats, but also has certain damage to the eyes of dogs and cats, and can induce inflammation such as conjunctivitis of the eyes of dogs and cats. (5) Influence on skeletal development: in haze weather, ultraviolet rays are greatly weakened, so that dogs and cats can not absorb enough ultraviolet rays easily, the efficiency of absorbing calcium is reduced, and the bone development of the dogs is caused. Among them, the damage to the respiratory tract and the cardiopulmonary system is particularly prominent.
The search for nutrients for intervening in air particulate matter damage is a research hotspot for reducing the damage of environmental fine particulate matters to living bodies. Currently, reports mostly focus on the prevention of the damage of air particles to human bodies, and reports of reducing or slowing down the air particles to pet dogs and cats are not found according to the physical structure characteristics of pets. The invention aims to develop a health care nutrition tablet for reducing the damage of air particles to the respiratory tract and the lung of the digestive tract of a pet dog or cat, and the health care nutrition tablet can enhance the defense of the pet dog or cat and the capacity of resisting the damage of the air particles to the respiratory tract and the lung so as to reduce or prevent the influence of the air particles on the damage or the disease of the respiratory tract and the lung of the pet, particularly the influence of frequent exposure to haze weather.
Disclosure of Invention
The invention aims to provide an active nutritional factor composition for preventing air particles from damaging canine and feline organisms, a product containing the composition and a preparation method, so as to solve the problems in the prior art and realize the effect of preventing the air particles from damaging the canine and feline organisms, particularly the respiratory tract and the heart and lung of pets.
In order to achieve the purpose, the invention provides the following scheme:
the invention aims to provide an active nutritional factor composition for preventing air particles from damaging dog and cat organisms, which comprises the following raw material components in parts by weight:
0.05-0.15 part of vitamin E, 60.01-0.05 part of vitamin B, 0.01-0.05 part of folic acid, 0.03-0.15 part of vitamin C, 0.01-0.5 part of Omega3 fatty acid, 0.01-0.1 part of natural triterpene saponin, 0.01-0.1 part of curcumin, 0.01-0.1 part of lycopene and 0.01-0.1 part of tea polyphenol.
Further, the active nutritional factor composition comprises the following raw material components in parts by weight: 0.05-0.1 part of vitamin E, 0.03-0.78 part of vitamin B60.015, 0.01-0.03 part of folic acid, 0.05-0.1 part of vitamin C, 0.1-0.25 part of Omega3 fatty acid, 0.025-0.05 part of natural triterpene saponin, 0.015-0.05 part of curcumin, 0.015-0.05 part of lycopene and 0.015-0.05 part of tea polyphenol.
The invention also aims to provide the active nutritional factor composition microcapsule powder which contains the active nutritional factor composition.
The invention also aims to provide a preparation method of the active nutritional factor composition microcapsule powder, which comprises the following steps:
(1) mixing a fat-soluble active nutritional factor and an emulsifier according to a mass ratio of 1: 1-10, and stirring to obtain a mixture A;
(2) mixing water-soluble active nutritional factors with water according to the mass ratio of 1: 5-15, stirring to obtain a mixture B;
(3) adding the mixture B into the mixture A, and stirring to obtain emulsion;
(4) and (3) carrying out spray drying on the emulsion to obtain the active nutritional factor composition microcapsule powder.
The fat-soluble active nutritional factors are vitamin E, Omega3 fatty acid, natural triterpene saponin, curcumin, lycopene and tea polyphenol.
The functions of the various active trophic factors are as follows: the vitamin E can improve airway epithelial injury and airway epithelial barrier dysfunction caused by air particles, reduce inflammatory factors, promote blood circulation of dogs and cats, prevent cholesterol oxidation and avoid coronary arteriosclerosis. Vitamin B6 can relieve cell inflammation and enhance immunity. Folic acid promotes cell growth. Vitamin C can reduce oxidative damage of lung cells. The Omega3 fatty acid can improve the activity of glutathione peroxidase, antioxidant enzyme and superoxide dismutase, and relieve the inflammatory reaction and oxidative stress injury of the heart-lung system caused by air particles to canine and feline organisms. The natural triterpene saponin has a certain protection effect on the growth inhibition of bronchial epithelial cells caused by air particles, and is related to the antioxidation effect of the natural triterpene saponin. Curcumin has antioxidant and anti-inflammatory effects. Lycopene can reduce oxidative damage of air particulate matter to airway epithelial cells. Meanwhile, the composition has the effects of removing blood vessel garbage of dogs and cats, regulating the concentration of blood plasma cholesterol and enhancing the flexibility of blood vessels of pets. The tea polyphenols have antioxidant and blood lipid reducing effects.
The emulsifier is polyethylene glycol glyceryl ricinoleate.
In the step (1), the stirring temperature is 20-30 ℃, and the stirring time is 15-30 min.
The water-soluble active nutritional factors comprise vitamin B6, folic acid and vitamin C.
The stirring time in the step (2) is 15-30min, and the stirring speed is 400-800 rpm.
The mass ratio of the emulsifier to the water is 1 (1-15);
the particle size of the microcapsule powder of the active nutritional factor composition is 100-250 mu m.
The invention also aims to provide a nutrition tablet for preventing air particles from damaging the bodies of dogs and cats, which contains the active nutritional factor composition.
The fifth purpose of the invention is to provide a preparation method of the nutrition tablet, which comprises the following steps:
(1) preparing the active nutritional factor composition into capsule powder according to the method of claim 3;
(2) mixing the active nutritional factor composition microcapsule powder, the additive and the main raw materials, granulating and drying to obtain the nutritional tablet.
The invention also aims to provide the staple food for preventing air particles from damaging the bodies of dogs and cats, and the active nutritional factor composition.
The seventh purpose of the invention is to provide a preparation method of the staple food grain, which comprises the following steps:
(1) preparing the active nutritional factor composition into capsule powder according to the method of claim 3;
(2) crushing: crushing the raw materials except the active nutritional factor composition microcapsule powder:
(3) mixing the mixture obtained in the step (2) with the active nutritional factor composition microcapsule powder, and tempering to obtain a tempered mixture;
(4) puffing and drying the tempered mixture to obtain material particles;
(5) adding chicken oil and flavoring agent, spraying the material particles, and sterilizing to obtain the staple food.
The invention also provides a snack for preventing air particles from damaging the bodies of dogs and cats, which contains the active nutritional factor composition.
The ninth purpose of the present invention is to provide a preparation method of the snack, which comprises the following steps:
mixing the main raw materials, the additive and the active nutritional factor composition microcapsule powder to obtain a mixture, and performing vacuum drying to obtain the snack.
Further, the method also comprises a step of compression molding before vacuum drying.
The invention discloses the following technical effects:
the product of the invention contains various nutritional active factors, and can prevent or reduce the damage of air pollution particles to pet dog and cat organisms in a multi-dimensional way (respiratory tract, lung and cardiovascular and cerebrovascular), especially the damage of the air particles to the respiratory tract and the heart and lung of the pet dog and cat.
The invention creatively combines and embeds the fat-soluble vitamin and the water-soluble vitamin through the nano emulsion, realizes the superposition of synergistic effect, embeds the active nutritional factors, is beneficial to realizing the slow release of the active ingredients in the bodies of dogs and cats, and is beneficial to improving the bioavailability of the active ingredients. Meanwhile, the vitamin E and the Omega3 fatty acid have a synergistic effect in the aspect of preventing and delaying the damage of air particles to the dog and cat organisms, and the vitamin C, the vitamin B6 and the folic acid also have a synergistic effect.
The product of the invention has good effect on preventing air particles from damaging canine and feline organisms, has simple preparation method and wide popularization and application prospect.
Detailed Description
Reference will now be made in detail to various exemplary embodiments of the invention, the detailed description should not be construed as limiting the invention but as a more detailed description of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. Further, for numerical ranges in this disclosure, it is understood that each intervening value, between the upper and lower limit of that range, is also specifically disclosed. Every smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in a stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference herein for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the present disclosure without departing from the scope or spirit of the disclosure. Other embodiments will be apparent to those skilled in the art from consideration of the specification. The description and examples are intended to be illustrative only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are open-ended terms that mean including, but not limited to.
The "parts" in the present invention are in parts by weight unless otherwise specified.
The active nutritional factor composition for preventing the air particles from damaging the bodies of dogs and cats comprises the following raw material components in parts by weight: 0.05-0.15 part of vitamin E, 60.01-0.05 part of vitamin B, 0.01-0.05 part of folic acid, 0.03-0.15 part of vitamin C, 0.01-0.5 part of Omega3 fatty acid, 0.01-0.1 part of natural triterpene saponin, 0.01-0.1 part of curcumin, 0.01-0.1 part of lycopene and 0.01-0.1 part of tea polyphenol.
Preferably, the active nutritional factor composition comprises the following raw material components in parts by weight: 0.05-0.1 part of vitamin E, 0.03-0.78 part of vitamin B60.015, 0.01-0.03 part of folic acid, 0.05-0.1 part of vitamin C, 0.1-0.25 part of Omega3 fatty acid, 0.025-0.05 part of natural triterpene saponin, 0.015-0.05 part of curcumin, 0.015-0.05 part of lycopene and 0.015-0.05 part of tea polyphenol.
Wherein, in the Omega3 fatty acid, ALA (EPA + DHA) is 0.5:1, EPA: the DHA is 2: 1.
The active nutritional factor composition can be prepared into microcapsule powder by embedding and microencapsulation treatment, and is used for preparing dog and cat nutritional tablets, staple food and snacks.
Secondly, the preparation steps of the active nutritional factor composition microcapsule powder are as follows:
(1) mixing fat-soluble active nutritional factors (vitamin E, Omega3 fatty acid, natural triterpene saponin, curcumin, lycopene and tea polyphenol) and polyethylene glycol glycerol ricinoleate (emulsifier) according to the mass ratio of 1: 1-10, and stirring at 20-30 deg.C for 15-30min to obtain mixture A;
(2) mixing water-soluble active nutritional factors (vitamin B6, folic acid and vitamin C) and water according to the mass ratio of 1: 5-15, stirring for 15-30min at the rotating speed of 400-800rpm to obtain a mixture B;
(3) dropwise adding the mixture B into the mixture A, and stirring to obtain emulsion; wherein the mass ratio of the emulsifier to the water is 1 (1-15);
(4) and (3) carrying out spray drying on the emulsion to obtain microcapsule powder for embedding the active nutritional factor composition, wherein the particle size of the microcapsule powder is 100-250 mu m, the equipment used for spray drying is a spray dryer, the inlet temperature of the spray dryer is 150-180 ℃, and the outlet temperature of the spray dryer is 60-80 ℃.
The invention relates to a nutrition tablet for preventing air particles from damaging dog and cat organisms, which comprises the following raw materials: the active nutritional factor composition, additive and main raw materials.
Specifically, the feed comprises the following raw material components in parts by weight according to 100 parts by weight:
the above active trophic factor compositions;
additive: 0.01-0.12 part of calcium carbonate, 0.1-2 parts of microcrystalline cellulose and 0.05-1 part of magnesium stearate;
the main raw materials are as follows: the cat nutrition tablet comprises the following main raw materials: 70-85 parts of chicken powder and the balance of beer yeast powder; the dog nutrition tablet comprises the following main raw materials: 2-8 parts of brown rice powder, 5-10 parts of corn flour, 2-8 parts of wheat germ, 2-8 parts of linseed powder, 60-80 parts of chicken meal and the balance of soybean protein concentrate.
Preferably, the additive: 0.02-0.1 part of light calcium carbonate, 0.2-1 part of microcrystalline cellulose and 0.1-0.5 part of magnesium stearate; the main raw materials are as follows: the cat nutrition tablet comprises the following main raw materials: 60-90 parts of chicken powder and the balance of beer yeast powder; the dog nutrition tablet comprises the following main raw materials: 2-8 parts of brown rice powder, 5-10 parts of corn flour, 2-8 parts of wheat germ, 2-8 parts of linseed powder, 60-80 parts of chicken meal and the balance of soybean protein concentrate.
Fourthly, the preparation method of the nutrition tablet for preventing air particles from damaging the bodies of dogs and cats comprises the following steps:
(1) mixing the active nutritional factor composition microcapsule powder, additives and main raw materials, sieving with a 100-mesh sieve, adding 70-75% ethanol water solution as wetting agent, adjusting material humidity, and making into soft material with hardness required to be kneaded into balls by hand, and dispersing by light pressing;
(2) placing the soft material in a granulator for granulation, and drying in a vacuum drying oven at 35-45 ℃ for 1-2 hours;
(3) adding magnesium stearate as lubricant, mixing, tabletting, irradiating under ultraviolet for 20-40min, sterilizing, and packaging to obtain nutritious tablet.
The staple food for preventing the air particles from damaging the pet cat body comprises the following components in parts by weight:
the main raw materials are as follows: 30-40 parts of chicken powder, 10-20 parts of duck powder, 5-10 parts of fish powder, 5-8 parts of chicken liver powder, 10-20 parts of pea powder, 10-15 parts of sweet potato powder, 3-5 parts of egg yolk, 2-4 parts of beer yeast powder, 0.5-2 parts of chicory root powder, 0.1-0.5 part of cranberry, 0.1-0.5 part of rosemary, 0.1-0.5 part of yushenghong haematococcus powder and 0.1-0.5 part of Yusheng haematococcus powder;
additive: 0.01-0.05 part of yeast selenium, 0.01-0.05 part of vitamin A, 30.01-0.05 part of vitamin D, 10.01-0.05 part of vitamin B, 0.01-0.05 part of D-biotin, 0.01-0.05 part of nicotinamide, 0.01-0.025 part of protein copper, 0.01-0.025 part of protein iron, 0.01-0.025 part of protein zinc, 0.01-0.025 part of protein manganese, 0.1-0.5 part of nisin, 0.01-0.05 part of milk calcium and 0.1-0.5 part of taurine;
and microcapsule powder of the active nutritional factor composition.
The pet cat staple food contains fruits and vegetables, vitamins, minerals, amino acids and the like.
The staple food for preventing air particles from damaging the body of a pet dog comprises the following components in parts by weight:
the main raw materials are as follows: 30-45 parts of chicken powder, 10-20 parts of duck powder, 5-8 parts of chicken liver powder, 15-25 parts of peas, 15-20 parts of sweet potato powder, 3-5 parts of chicken oil, 3-5 parts of beer yeast powder, 5-8 parts of fish meal, 0.1-0.5 part of kelp powder, 0.1-0.5 part of ulva powder, 0.1-0.5 part of carrot powder and 0.1-0.5 part of wolfberry powder.
Additive: 0.1 to 0.5 portion of glucosamine hydrochloride, 0.1 to 0.5 portion of L-lysine hydrochloride, 0.1 to 0.5 portion of fructo-oligosaccharide, 0.1 to 0.5 portion of chondroitin sulfate, 0.1 to 0.5 portion of DL-methionine, 0.01 to 0.05 portion of vitamin A, 30.01 to 0.05 portion of vitamin D, 20.01 to 0.05 portion of vitamin B, 120.01 to 0.05 portion of vitamin B, 0.01 to 0.05 portion of calcium pantothenate, 0.01 to 0.025 portion of sodium selenite, 0.01 to 0.025 portion of copper sulfate, 0.01 to 0.025 portion of zinc sulfate, 0.01 to 0.025 portion of calcium hydrophosphate and 0.01 to 0.025 portion of choline chloride.
And microcapsule powder of the active nutritional factor composition.
The pet dog staple food contains fruits and vegetables, vitamins, minerals, amino acids, auxiliary additives and the like.
Sixth, the preparation method of the staple food for preventing air particles from damaging dog and cat bodies comprises the following steps:
(1) crushing: crushing the raw materials except the active nutritional factor composition microcapsule powder and sieving the crushed raw materials with a 90-mesh sieve;
(2) tempering: adding active nutritional factor composition microcapsule powder into the mixture obtained in the step (1), mixing, and carrying out low-temperature (20-30 ℃) tempering to obtain a tempered mixture;
(3) puffing and drying: extruding and puffing the modified mixture at the puffing temperature of 120-;
(4) spraying: adding chicken oil and flavoring agent, spraying on the dried material particles, and sterilizing at low temperature.
Seventh, the snack for preventing the damage of air particles to the bodies of dogs and cats comprises the following raw materials in parts by weight:
the main raw materials are as follows: 70-85 parts of fish meal (35% of salmon, 35% of cod, 25% of tuna and 5% of salmon roe), 3-5 parts of beef tallow, 3-5 parts of egg yolk, 2-4 parts of beer yeast powder, 0.5-2 parts of chicory root powder, 0.1-0.5 part of plantain seed, 0.1-0.5 part of haematococcus pluvialis powder, 0.1-0.5 part of blueberry, 0.1-0.5 part of rosemary and 0.1-0.5 part of yulan powder.
Additive: 0.01-0.05 part of yeast selenium, 0.1-0.5 part of fructo-oligosaccharide, 0.1-0.5 part of xylooligosaccharide, 0.01-0.05 part of vitamin A, 30.01-0.05 part of vitamin D, 10.01-0.05 part of vitamin B, 20.01-0.05 part of vitamin B, 0.05-0.05 part of vitamin B120.01, 10.01-0.05 part of vitamin K, 0.01-0.05 part of D-biotin, 0.01-0.05 part of nicotinamide, 0.01-0.05 part of protein copper, 0.01-0.025 part of protein iron, 0.01-0.025 part of protein zinc, 0.01-0.025 part of protein manganese, 0.1-0.5 part of nisin, 0.01-0.05 part of milk calcium and 0.1-0.5 part of taurine.
And microcapsule powder of the active nutritional factor composition.
The snack food for dogs and cats contains fruits and vegetables, vitamins, minerals, amino acids, auxiliary additives and the like.
Eighthly, the preparation method of the dog and cat snack provided by the invention comprises the following steps:
mixing the main raw materials, the additive and the active nutritional factor composition microcapsule powder to obtain a mixture, then forming in a specific mould, and carrying out vacuum drying at 60-80 ℃ for 30-50 minutes to obtain the pet dog and cat snack with a specific shape.
The staple food and snack of the present invention may also contain a preservative, such as the biological preservative nisin.
Example 1
A nutrition tablet for preventing air particles from damaging pet cat organisms comprises the following components in parts by weight, based on 100 parts by weight:
active nutritional factor composition: 0.05 part of vitamin E, 60.015 parts of vitamin B, 0.01 part of folic acid, 0.05 part of vitamin C, 0.1 part of Omega3 fatty acid, 0.025 part of natural triterpene saponin, 0.015 part of curcumin, 0.015 part of lycopene and 0.02 part of tea polyphenol;
additive: 0.1 part of light calcium carbonate, 1 part of microcrystalline cellulose and 0.1 part of magnesium stearate;
the main raw materials are as follows: 80 parts of chicken powder and the balance of beer yeast powder.
The preparation method comprises the following steps:
(1) mixing fat-soluble active nutritional factors (vitamin E, Omega3 fatty acid, natural triterpene saponin, curcumin, lycopene and tea polyphenol) and polyethylene glycol glycerol ricinoleate (emulsifier) according to the mass ratio of 1:10, stirring for 20min at 30 ℃ to obtain a mixture A;
(2) mixing water-soluble active nutritional factors (vitamin B6, folic acid and vitamin C) and water according to the mass ratio of 1: 5, mixing, and stirring at the rotating speed of 800rpm for 15min to obtain a mixture B;
(3) dropwise adding the mixture B into the mixture A, and stirring to obtain emulsion; wherein the mass ratio of the emulsifier to the water is 1: 1;
(4) and (3) carrying out spray drying on the emulsion to obtain microcapsule powder embedding the active nutritional factor composition, wherein the particle size of the microcapsule powder is 100 microns, the spray drying equipment is a spray dryer, the inlet temperature of the spray dryer is 180 ℃, and the outlet temperature of the spray dryer is 70 ℃.
(5) Mixing the active nutritional factor composition microcapsule powder, the additive and the main raw materials, sieving with a 100-mesh sieve, adding 75% ethanol water solution with volume concentration as a wetting agent, adjusting the humidity of the materials, and preparing into soft materials, wherein the hardness of the soft materials requires to be kneaded into balls by hand, and the soft materials are scattered by light pressing;
(6) placing the soft material in a granulator for granulation, and drying in a vacuum drying oven at 35 ℃ for 2 hours;
(7) adding magnesium stearate as lubricant, mixing, tabletting, irradiating the tablet under ultraviolet for 40min, sterilizing, and packaging to obtain nutritious tablet.
Example 2
A nutrition tablet for preventing air particles from damaging pet dog bodies comprises the following components in parts by weight, based on 100 parts by weight:
active nutritional factor composition: 0.05 part of vitamin E, 60.015 parts of vitamin B, 0.01 part of folic acid, 0.05 part of vitamin C, 0.15 part of Omega3 fatty acid, 0.025 part of natural triterpene saponin, 0.015 part of curcumin, 0.015 part of lycopene and 0.015 part of tea polyphenol;
additive: 0.1 part of light calcium carbonate, 1 part of microcrystalline cellulose and 0.1 part of magnesium stearate;
the main raw materials are as follows: 4 parts of brown rice powder, 8 parts of corn powder, 4 parts of wheat germ, 4 parts of flaxseed powder, 68 parts of chicken powder and the balance of soybean protein concentrate.
The preparation method is the same as example 1.
Example 3
A nutrition tablet for preventing air particles from damaging pet cat organisms comprises the following components in parts by weight, based on 100 parts by weight:
active nutritional factor composition: 0.06 part of vitamin E, 60.01 parts of vitamin B, 0.02 part of folic acid, 0.07 part of vitamin C, 0.15 part of Omega3 fatty acid, 0.03 part of natural triterpene saponin, 0.02 part of curcumin, 0.02 part of lycopene and 0.02 part of tea polyphenol;
additive: 0.1 part of light calcium carbonate, 1 part of microcrystalline cellulose and 0.1 part of magnesium stearate;
the main raw materials are as follows: 85 parts of chicken powder and the balance of beer yeast powder.
The preparation method comprises the following steps:
(1) mixing fat-soluble active nutritional factors (vitamin E, Omega3 fatty acid, natural triterpene saponin, curcumin, lycopene and tea polyphenol) and polyethylene glycol glycerol ricinoleate (emulsifier) according to the mass ratio of 1: 5, stirring for 15min at 20 ℃ to obtain a mixture A;
(2) mixing water-soluble active nutritional factors (vitamin B6, folic acid and vitamin C) and water according to the mass ratio of 1:15, stirring for 30min at the rotating speed of 400rpm to obtain a mixture B;
(3) dropwise adding the mixture B into the mixture A, and stirring to obtain emulsion; wherein the mass ratio of the emulsifier to the water is 1: 15;
(4) and (3) carrying out spray drying on the emulsion to obtain microcapsule powder embedding the active nutritional factor composition, wherein the particle size of the microcapsule powder is 200 mu m, the spray drying equipment is a spray dryer, the inlet temperature of the spray dryer is 150 ℃, and the outlet temperature of the spray dryer is 80 ℃.
(5) Mixing the active nutritional factor composition microcapsule powder, the additive and the main raw materials, sieving with a 100-mesh sieve, adding 70% ethanol water solution with volume concentration as a wetting agent, adjusting the humidity of the materials, and preparing into soft materials, wherein the hardness of the soft materials requires to be kneaded into balls by hand, and the soft materials are scattered by light pressing;
(6) placing the soft material in a granulator for granulation, and drying in a vacuum drying oven at 40 ℃ for 1 hour;
(7) adding magnesium stearate as lubricant, mixing, tabletting, irradiating under ultraviolet for 20min, sterilizing, and packaging to obtain nutritious tablet.
Example 4
A nutrition tablet for preventing air particles from damaging pet dog bodies comprises the following components in parts by weight, based on 100 parts by weight:
active nutritional factor composition: 0.05 part of vitamin E, 60.015 parts of vitamin B, 0.01 part of folic acid, 0.05 part of vitamin C, 0.15 part of Omega3 fatty acid, 0.025 part of natural triterpene saponin, 0.015 part of curcumin, 0.015 part of lycopene and 0.02 part of tea polyphenol;
additive: 0.05 part of light calcium carbonate, 0.5 part of microcrystalline cellulose and 0.2 part of magnesium stearate;
the main raw materials are as follows: 3 parts of brown rice powder, 6 parts of corn powder, 4 parts of wheat germ, 4 parts of flaxseed powder, 70 parts of chicken powder and the balance of soybean protein concentrate.
The preparation method is the same as example 3.
Example 5
A nutrition tablet for preventing air particles from damaging pet cat organisms comprises the following components in parts by weight, based on 100 parts by weight:
active nutritional factor composition: 0.08 part of vitamin E, 60.02 parts of vitamin B, 0.01 part of folic acid, 0.1 part of vitamin C, 0.35 part of Omega3 fatty acid, 0.04 part of natural triterpene saponin, 0.02 part of curcumin, 0.03 part of lycopene and 0.02 part of tea polyphenol;
additive: 0.1 part of light calcium carbonate, 0.8 part of microcrystalline cellulose and 0.4 part of magnesium stearate;
the main raw materials are as follows: 83 parts of chicken powder and the balance of beer yeast powder.
The preparation method comprises the following steps:
(1) mixing fat-soluble active nutritional factors (vitamin E, Omega3 fatty acid, natural triterpene saponin, curcumin, lycopene and tea polyphenol) and polyethylene glycol glycerol ricinoleate (emulsifier) according to the mass ratio of 1:1, and stirring for 30min at 25 ℃ to obtain a mixture A;
(2) mixing water-soluble active nutritional factors (vitamin B6, folic acid and vitamin C) and water according to the mass ratio of 1:10, mixing, and stirring at the rotating speed of 600rpm for 20min to obtain a mixture B;
(3) dropwise adding the mixture B into the mixture A, and stirring to obtain emulsion; wherein the mass ratio of the emulsifier to the water is 1: 10;
(4) and (3) carrying out spray drying on the emulsion to obtain microcapsule powder embedding the active nutritional factor composition, wherein the particle size of the microcapsule powder is 250 microns, the spray drying equipment is a spray dryer, the inlet temperature of the spray dryer is 170 ℃, and the outlet temperature of the spray dryer is 60 ℃.
(5) Mixing the active nutritional factor composition microcapsule powder, the additive and the main raw materials, sieving with a 100-mesh sieve, adding 72% ethanol aqueous solution as a wetting agent, adjusting the humidity of the materials, and preparing into soft materials, wherein the hardness of the soft materials requires to be kneaded into balls by hand, and the soft materials are dispersed by light pressure;
(6) placing the soft material in a granulator for granulation, and drying in a vacuum drying oven at 45 ℃ for 1 hour;
(7) adding magnesium stearate as lubricant, mixing, tabletting, irradiating under ultraviolet for 30min, sterilizing, and packaging to obtain nutritious tablet.
Example 6
A nutrition tablet for preventing air particles from damaging pet dog bodies comprises the following components in parts by weight, based on 100 parts by weight:
active nutritional factor composition: 0.05 part of vitamin E, 60.02 parts of vitamin B, 0.01 part of folic acid, 0.1 part of vitamin C, 0.4 part of Omega3 fatty acid, 0.025 part of natural triterpene saponin, 0.025 part of curcumin, 0.025 part of lycopene and 0.015 part of tea polyphenol;
additive: 0.1 part of light calcium carbonate, 0.7 part of microcrystalline cellulose and 0.5 part of magnesium stearate;
the main raw materials are as follows: 5 parts of brown rice powder, 6 parts of corn powder, 5 parts of wheat germ, 3 parts of flaxseed powder, 70 parts of chicken powder and the balance of soybean protein concentrate.
The preparation method is the same as example 5.
Example 7
A nutrition tablet for preventing air particles from damaging pet cat organisms comprises the following components in parts by weight, based on 100 parts by weight:
active nutritional factor composition: 0.1 part of vitamin E, 60.03 parts of vitamin B, 0.03 part of folic acid, 0.1 part of vitamin C, 0.5 part of Omega3 fatty acid, 0.06 part of natural triterpene saponin, 0.02 part of curcumin, 0.025 part of lycopene and 0.02 part of tea polyphenol;
additive: 0.08 part of light calcium carbonate, 1 part of microcrystalline cellulose and 0.5 part of magnesium stearate;
the main raw materials are as follows: 80 parts of chicken powder and the balance of beer yeast powder.
The preparation method is the same as example 5.
Example 8
A nutrition tablet for preventing air particles from damaging pet dog bodies comprises the following components in parts by weight, based on 100 parts by weight:
active nutritional factor composition: 0.1 part of vitamin E, 60.03 parts of vitamin B, 0.03 part of folic acid, 0.1 part of vitamin C, 0.5 part of Omega3 fatty acid, 0.02 part of natural triterpene saponin, 0.02 part of curcumin, 0.02 part of lycopene and 0.025 part of tea polyphenol;
additive: 0.05 part of light calcium carbonate, 0.9 part of microcrystalline cellulose and 0.4 part of magnesium stearate;
the main raw materials are as follows: 3 parts of brown rice powder, 8 parts of corn powder, 3 parts of wheat germ, 3 parts of flaxseed powder, 72 parts of chicken powder and the balance of soybean protein concentrate.
The preparation method is the same as example 5.
Example 9
The staple food for preventing air particles from damaging pet cat bodies comprises the following components in parts by weight:
the main raw materials are as follows: 35 parts of chicken powder, 15 parts of duck powder, 6 parts of fish powder, 7 parts of chicken liver powder, 12 parts of pea powder, 13 parts of sweet potato powder, 4 parts of egg yolk, 3 parts of beer yeast powder, 1 part of chicory root powder, 0.2 part of cranberry, 0.3 part of rosemary, 0.4 part of yushenghong haematococcus powder;
additive: 0.03 part of yeast selenium, 0.02 part of vitamin A, 30.03 parts of vitamin D, 10.05 parts of vitamin B, 0.03 part of D-biotin, 0.03 part of nicotinamide, 0.02 part of protein copper, 0.02 part of protein iron, 0.01 part of protein zinc, 0.02 part of protein manganese, 0.3 part of nisin, 0.05 part of milk calcium and 0.1 part of taurine;
and microcapsule powder of the active nutritional factor composition prepared in example 1.
The preparation method comprises the following steps:
(1) crushing: crushing the raw materials except the active nutritional factor composition microcapsule powder and sieving the crushed raw materials with a 90-mesh sieve;
(2) tempering: adding active nutritional factor composition microcapsule powder into the mixture obtained in the step (1), mixing, and carrying out low-temperature (30 ℃) tempering to obtain a tempered mixture;
(3) puffing and drying: extruding and puffing the tempered mixture at a puffing temperature of 120 ℃, granulating to obtain material particles, and drying the material particles at 120 ℃ to control the water content to be 6%;
(4) spraying: adding chicken oil and flavoring agent, spraying on the dried material particles, and sterilizing at low temperature to obtain staple food.
Example 10
The staple food for preventing air particles from damaging pet dog bodies comprises the following components in parts by weight:
the main raw materials are as follows: 35 parts of chicken powder, 15 parts of duck powder, 6 parts of chicken liver powder, 20 parts of peas, 17 parts of sweet potato powder, 4 parts of chicken oil, 4 parts of beer yeast powder, 6 parts of fish meal, 0.2 part of kelp powder, 0.3 part of ulva powder, 0.3 part of carrot powder and 0.3 part of wolfberry powder.
Additive: 0.3 part of glucosamine hydrochloride, 0.4 part of L-lysine hydrochloride, 0.4 part of fructooligosaccharide, 0.3 part of chondroitin sulfate, 0.2 part of DL-methionine, 0.03 part of vitamin A, 30.02 parts of vitamin D, 20.03 parts of vitamin B, 120.04 parts of vitamin B, 0.03 part of calcium pantothenate, 0.01 part of sodium selenite, 0.025 part of copper sulfate, 0.025 part of zinc sulfate, 0.01 part of calcium hydrophosphate and 0.01 part of choline chloride.
And microcapsule powder of the active nutritional factor composition prepared in example 1.
The preparation method comprises the following steps:
(1) crushing: crushing the raw materials except the active nutritional factor composition microcapsule powder and sieving the crushed raw materials with a 90-mesh sieve;
(2) tempering: adding active nutritional factor composition microcapsule powder into the mixture obtained in the step (1), mixing, and carrying out low-temperature (20 ℃) tempering to obtain a tempered mixture;
(3) puffing and drying: extruding and puffing the tempered mixture at a puffing temperature of 125 ℃, granulating to obtain material particles, drying the material particles at 115 ℃, and controlling the moisture content to be 8%;
(4) spraying: adding chicken oil and flavoring agent, spraying on the dried material particles, and sterilizing at low temperature to obtain staple food.
Example 11
The snack capable of preventing air particles from damaging bodies of dogs and cats comprises the following raw materials in parts by weight:
the main raw materials are as follows: 75 parts of fish meal (35% of salmon, 35% of cod, 25% of tuna and 5% of salmon roe), 4 parts of beef tallow, 4 parts of egg yolk, 3 parts of beer yeast powder, 1 part of chicory root powder, 0.3 part of plantain seed, 0.3 part of haematococcus pluvialis powder, 0.2 part of blueberry, 0.3 part of rosemary and 0.2 part of yucca powder.
Additive: 0.02 part of yeast selenium, 0.2 part of fructo-oligosaccharide, 0.2 part of xylo-oligosaccharide, 0.02 part of vitamin A, 30.03 parts of vitamin D, 10.03 parts of vitamin B, 20.02 parts of vitamin B, 120.03 parts of vitamin B, 10.02 parts of vitamin K, 0.02 part of D-biotin, 0.03 part of nicotinamide, 0.01 part of protein copper, 0.01 part of protein iron, 0.01 part of protein zinc, 0.02 part of protein manganese, 0.2 part of nisin, 0.02 part of milk calcium and 0.3 part of taurine.
And microcapsule powder of the active nutritional factor composition prepared in example 1.
The preparation method comprises the following steps:
mixing the main raw materials, the additives and the active nutritional factor composition microcapsule powder to obtain a mixture, then forming the mixture in a specific mould, and carrying out vacuum drying at 70 ℃ for 40 minutes to obtain the pet dog and cat snack with a specific shape.
Comparative example 1
The difference from example 1 is that the active nutritional factor composition is not microencapsulated and added by conventional mixing means.
Comparative example 2
Except for the difference from example 2, vitamin E was adjusted to 0.25 parts and Omega3 fatty acid was adjusted to 0.6 parts.
Comparative example 3
The difference from example 3 is that 0.20 parts of vitamin C, 0.06 parts of vitamin B6 and 0.06 parts of folic acid are adjusted.
Effect verification example 1:
experimental animals: 48 healthy adult ordinary domestic cats with half male and female are averagely divided into 6 groups (the age, weight and sex of each group are not obviously different), and the groups are respectively used as a blank control group, a negative control group and test groups 1-4.
Blank control group: the domestic cat growth gas environment is a normal gas environment in which PM2.5 and PM10 do not exceed the standard;
the domestic cat growth gas environment of the negative control group and the test groups 1 to 4 is the gas environment exceeding two times of that of PM2.5 and PM 10.
On the basis of daily staple food, domestic cats in a blank control group and a negative control group eat the conventional nutrition tablets conventionally, and domestic cats in test groups 1-4 correspondingly eat the nutrition tablets in examples 1, 3, 5 and 7 (the nutrition tablets in all groups have the same eating amount, and the conventional dosage of the conventional nutrition tablets is adopted). The experimental period is 3 months, and the rest feeding conditions of all groups of domestic cats are the same during the experimental period. After the experiment is finished, the conditions of respiratory diseases such as chronic airway diseases, chronic bronchitis, asthma, chronic obstructive pulmonary disease or cystic fibrosis and the conditions of cardiopulmonary injury diseases such as chronic obstructive pulmonary disease and cardiovascular disease of each group of domestic cats are counted, and the statistical results are shown in table 1.
TABLE 1
Effect verification example 2:
experimental animals: the healthy adult beagle dogs are divided into 6 groups (the age, the weight and the sex of each group are not obviously different) by 48 dogs, and the groups are respectively used as a blank control group, a negative control group and test groups 1-4.
Blank control group: the beagle gas environment is a normal gas environment in which both PM2.5 and PM10 do not exceed the standard;
the beagle growth gas environment of the negative control group and the test groups 1 to 4 is the gas environment exceeding two times of that of PM2.5 and PM 10.
On the basis of daily staple food, the conventional nutrition tablets are eaten by the beagle dogs in the blank control group and the negative control group, and the nutrition tablets in examples 2, 4, 6 and 8 are eaten by the beagle dogs in the test groups 1-4 correspondingly (the eating amount of the nutrition tablets in each group is the same, and the conventional dosage of the conventional nutrition tablets is adopted). The experimental period is 3 months, and the rest feeding conditions of the beagle dogs in each group are the same during the experimental period. After the experiment is finished, the conditions of respiratory diseases such as chronic airway diseases, chronic bronchitis, asthma, chronic obstructive pulmonary diseases or cystic fibrosis and the conditions of cardiopulmonary injury diseases such as chronic obstructive pulmonary diseases and cardiovascular diseases of each group of beagle dogs are counted, and the statistical results are shown in table 2.
TABLE 2
Effect test example 3
Experimental animals: the healthy adult ordinary domestic cats are divided into 3 groups (each group has no obvious difference in age, weight and sex) by 48 animals, and the groups are respectively used as a blank control group, a negative control group and a test group.
Blank control group: the domestic cat growth gas environment is a normal gas environment in which PM2.5 and PM10 do not exceed the standard;
the domestic cat growth gas environment of the negative control group and the test group is the gas environment which exceeds two times of that of PM2.5 and PM 10.
The blank control group and the negative control group of domestic cats eat the conventional staple food, and the test group of domestic cats eat the staple food of the example 9, and the daily food consumption of each group is the same. The experimental period is 3 months, and the rest feeding conditions of all groups of domestic cats are the same during the experimental period. After the experiment is finished, the conditions of respiratory diseases such as chronic airway diseases, chronic bronchitis, asthma, chronic obstructive pulmonary disease or cystic fibrosis and the conditions of cardiopulmonary injury diseases such as chronic obstructive pulmonary disease and cardiovascular disease of each group of domestic cats are counted, and the statistical results are shown in table 3.
TABLE 3
Effect test example 4
Experimental animals: the healthy adult beagle dogs 48, half of the male and female dogs, were divided into 3 groups on average (each group had no significant difference in age, weight, and sex), and served as a blank control group, a negative control group, and a test group, respectively.
Blank control group: the domestic cat growth gas environment is a normal gas environment in which PM2.5 and PM10 do not exceed the standard;
the domestic cat growth gas environment of the negative control group and the test group is the gas environment which exceeds two times of that of PM2.5 and PM 10.
The blank control group and the negative control group beagle dogs eat conventional staple food, and the domestic cats in the test group eat the staple food in the example 10, and the daily food consumption of each group is the same. The experimental period is 3 months, and the rest feeding conditions of the beagle dogs in each group are the same during the experimental period. After the experiment, the status of each group of beagle dogs with respiratory diseases such as chronic airway diseases, chronic bronchitis, asthma, chronic obstructive pulmonary disease or cystic fibrosis and with cardiopulmonary injury diseases such as chronic obstructive pulmonary disease and cardiovascular disease is counted, and the statistical results are shown in table 4.
TABLE 4
Effect test example 5
Experimental animals: the healthy adult domestic cats, which are half male and half female, are divided into 3 groups on average (the groups have no significant difference in age, weight and sex), and the groups are used as a blank control group, a negative control group and a test group respectively.
Blank control group: the domestic cat growth gas environment is a normal gas environment in which PM2.5 and PM10 do not exceed the standard;
the domestic cat growth gas environment of the negative control group and the test group is the gas environment which exceeds two times of that of PM2.5 and PM 10.
The blank control group, the negative control group and the test group of domestic cats all eat the conventional staple food, and the daily food consumption of each group is the same. On the basis of daily staple food, the domestic cats in the blank control group and the negative control group normally eat 5g of the conventional snacks per day, and the domestic cats in the test group eat 5g of the snacks of example 11 per day. The experimental period is 3 months, and the rest feeding conditions of all groups of domestic cats are the same during the experimental period. After the experiment is finished, the conditions of respiratory diseases such as chronic airway diseases, chronic bronchitis, asthma, chronic obstructive pulmonary disease or cystic fibrosis and the conditions of cardiopulmonary injury diseases such as chronic obstructive pulmonary disease and cardiovascular disease of each group of domestic cats are counted, and the statistical results are shown in table 5.
TABLE 5
The above-described embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solutions of the present invention can be made by those skilled in the art without departing from the spirit of the present invention, and the technical solutions of the present invention are within the scope of the present invention defined by the claims.
Claims (10)
1. An active nutritional factor composition for preventing air particles from damaging dog and cat organisms is characterized by comprising the following raw material components in parts by weight:
0.05-0.15 part of vitamin E, 60.01-0.05 part of vitamin B, 0.01-0.05 part of folic acid, 0.03-0.15 part of vitamin C, 0.01-0.5 part of Omega3 fatty acid, 0.01-0.1 part of natural triterpene saponin, 0.01-0.1 part of curcumin, 0.01-0.1 part of lycopene and 0.01-0.1 part of tea polyphenol.
2. An active nutritional factor composition microcapsule powder comprising the active nutritional factor composition according to claim 1.
3. The method for preparing the microcapsule powder of an active nutritional factor composition according to claim 2, comprising the steps of:
(1) mixing a fat-soluble active nutritional factor and an emulsifier according to a mass ratio of 1: 1-10, and stirring to obtain a mixture A;
(2) mixing water-soluble active nutritional factors with water according to the mass ratio of 1: 5-15, stirring to obtain a mixture B;
(3) adding the mixture B into the mixture A, and stirring to obtain emulsion;
(4) and (3) carrying out spray drying on the emulsion to obtain the active nutritional factor composition microcapsule powder.
4. A nutritional tablet for preventing air particulate matter from damaging the bodies of dogs and cats, comprising the active nutritional factor composition of claim 1.
5. The method of making a nutritional tablet according to claim 4 comprising the steps of:
(1) preparing the active nutritional factor composition into capsule powder according to the method of claim 3;
(2) mixing the active nutritional factor composition microcapsule powder, the additive and the main raw materials, granulating and drying to obtain the nutritional tablet.
6. A staple food for preventing airborne particulates from damaging the body of dogs and cats comprising the active nutritional factor composition of claim 1.
7. The preparation method of the staple food grain of claim 6, comprising the steps of:
(1) preparing the active nutritional factor composition into capsule powder according to the method of claim 3;
(2) crushing: crushing the raw materials except the active nutritional factor composition microcapsule powder:
(3) mixing the mixture obtained in the step (2) with the active nutritional factor composition microcapsule powder, and tempering to obtain a tempered mixture;
(4) puffing and drying the tempered mixture to obtain material particles;
(5) adding chicken oil and flavoring agent, spraying the material particles, and sterilizing to obtain the staple food.
8. A snack food for preventing airborne particulates from damaging the body of a dog or cat comprising the active nutrient composition of claim 1.
9. The method of snack preparation of claim 8, comprising the steps of:
mixing the main raw materials, the additive and the active nutritional factor composition microcapsule powder to obtain a mixture, and performing vacuum drying to obtain the snack.
10. The method of claim 9, further comprising the step of compression molding prior to vacuum drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111546343.4A CN114190487A (en) | 2021-12-16 | 2021-12-16 | Active nutritional factor composition for preventing air particles from damaging dog and cat organisms, product containing active nutritional factor composition and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111546343.4A CN114190487A (en) | 2021-12-16 | 2021-12-16 | Active nutritional factor composition for preventing air particles from damaging dog and cat organisms, product containing active nutritional factor composition and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114190487A true CN114190487A (en) | 2022-03-18 |
Family
ID=80654661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111546343.4A Pending CN114190487A (en) | 2021-12-16 | 2021-12-16 | Active nutritional factor composition for preventing air particles from damaging dog and cat organisms, product containing active nutritional factor composition and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114190487A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114586896A (en) * | 2022-03-31 | 2022-06-07 | 卫仕宠物营养研究院(芜湖)有限公司 | Calcium peptide nutritional composition freeze-dried particles for efficiently enhancing calcium absorption of pet dogs and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726572A (en) * | 2016-03-03 | 2016-07-06 | 东阿阿胶股份有限公司 | Application of donkey-hide gelatins to preparation of medicament or healthcare product for treating respiratory injury caused by fine air particulate matters |
CN106478832A (en) * | 2016-11-07 | 2017-03-08 | 安徽利民生物科技股份有限公司 | A kind of anti-fog haze protects the preparation method of lung ganoderan |
CN106479101A (en) * | 2015-08-25 | 2017-03-08 | 南京理工大学 | A kind of moisture-absorbing moisture-keeping type is combined small particle Fugitive dust inhibiting agent and preparation method thereof |
-
2021
- 2021-12-16 CN CN202111546343.4A patent/CN114190487A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106479101A (en) * | 2015-08-25 | 2017-03-08 | 南京理工大学 | A kind of moisture-absorbing moisture-keeping type is combined small particle Fugitive dust inhibiting agent and preparation method thereof |
CN105726572A (en) * | 2016-03-03 | 2016-07-06 | 东阿阿胶股份有限公司 | Application of donkey-hide gelatins to preparation of medicament or healthcare product for treating respiratory injury caused by fine air particulate matters |
CN106478832A (en) * | 2016-11-07 | 2017-03-08 | 安徽利民生物科技股份有限公司 | A kind of anti-fog haze protects the preparation method of lung ganoderan |
Non-Patent Citations (1)
Title |
---|
邓芙蓉: "空气颗粒物与健康", 湖北科学技术出版社, pages: 137 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114586896A (en) * | 2022-03-31 | 2022-06-07 | 卫仕宠物营养研究院(芜湖)有限公司 | Calcium peptide nutritional composition freeze-dried particles for efficiently enhancing calcium absorption of pet dogs and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105166420A (en) | Adsorption antidote capable of eliminating harm done by mycotoxins to livestock | |
CN105594994A (en) | Mildew-proof detoxication and detoxification mixed type feed additive | |
Attia et al. | Effect of feed form, pellet diameter and enzymes supplementation on carcass characteristics, meat quality, blood plasma constituents and stress indicators of broilers | |
KR102303298B1 (en) | Feed composition containing mealworm | |
CN106858147A (en) | A kind of draft selenium-enriched SOD antibiotic-free feed and preparation method thereof | |
Rabie et al. | Influence of some honey bee products and a growth promoter supplementation on productive and physiological performance of broiler chickens | |
CN108967692B (en) | Antibiotic-free suckling pig creep feed and preparation method thereof | |
Kamel et al. | Effect of dietary zinc-oxide or nano-zinc oxide on growth performance, oxidative stress, and immunity of growing rabbits under hot climate conditions | |
Delavari et al. | Modulatory effect of dietary copper nanoparticles and vitamin C supplementations on growth performance, hematological and immune parameters, oxidative status, histology, and disease resistance against Yersinia ruckeri in rainbow trout (Oncorhynchus mykiss) | |
WO2022127243A1 (en) | Cherax quadricarinatus fish meal-free compound feed and preparation method therefor | |
CN111838442A (en) | Pet dog and cat lysozyme functional food and preparation method thereof | |
CN114190487A (en) | Active nutritional factor composition for preventing air particles from damaging dog and cat organisms, product containing active nutritional factor composition and preparation method | |
Farooq et al. | Supplementation of herbal seeds to improve the growth performance and digestion in Japanese quail (Coturnix coturnix Japonica) | |
M AZAB et al. | Antioxidant and immunomodulatory effects of nano-selenium on response of broilers to ND vaccine | |
Aldal’in et al. | Use of zinc nanoparticles and/or prodigiosin to mitigate heat stress in rabbits | |
CN115606703A (en) | Dog and cat food and preparation method thereof | |
KR102228035B1 (en) | Method of producing eco-friendly quail feed composition containing bamboo salt | |
S Mahmood et al. | Influence of Nano-zinc Oxide and Zinc Sulfate on Some Hematological Values and Liver Function in Broiler Under High Ambient Temperature | |
Elfiky et al. | Productive performance and egg quality traits of laying hens fed on diets treated with nano-selenium under hot desert conditions | |
Mohamed et al. | Effect of dietary organic selenium on productive performance of broiler chickens under summer conditions | |
Deko et al. | The use of garlic (Allium sativum linn) bulb and husk powder as an organic feed additive on egg quality of laying hens | |
Jankowski et al. | Redox and immunological status of turkeys fed diets with different levels and sources of copper | |
Eldeeb et al. | Impact of adding different levels of nanoselenium to duck diets on growth performance, immunity status, antioxidant activity and some blood parameters | |
Prakash et al. | Effect of Dietary Inclusion of Neem Leaf Powder on Growth Performance, Nutrient Utilization, and Haemato-Biochemical Parameters of Japanese Quail | |
CN106615653A (en) | Antibacterial growth-helping animal feed and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220318 |